Author

Uladzislau Naidzionak

Observed names: U. A. Naidzionak, Ulad Naidzionak

Institutions: University of Missouri Health System, University of Missouri

Observed institutions: University of Missouri Health System, East West Medical Research Institute, University of Missouri

OpenAlex ID: A5087876799

Phase II, Multicenter, Uncontrolled Trial of Single-agent Capecitabine in Patients With Non-clear Cell Metastatic Renal Cell Carcinoma

2011 · Ilya Tsimafeyeu, Lev Demidov, et al. · American Journal of Clinical Oncology · 24

Thromboprophylaxis and Incidence of Venous Thromboembolism in Patients With Hemophilia A or B Who Underwent High-Risk Orthopedic Surgeries

2014 · Shahzad Raza, Gautam Kale, et al. · Clinical and Applied Thrombosis/Hemostasis · 21

Chronic Lymphocytic Leukemia-Associated Chromosomal Abnormalities and Risk of Secondary Malignancies

2014 · Shahzad Raza, Paul J Hampel, et al. · Blood · 1

Capecitabine in combination with interferon-alpha in interleukin-2-refractory metastatic renal cell carcinoma (MRCC)

2008 · L. V. Demidov, I. V. Tsimafeyeu, et al. · Journal of Clinical Oncology · 1

Correlation of high metabolic activity on 18F-FDG PET-CT at diagnosis with early relapse and mortality for patients with primary lung cancer.

2014 · Shahzad Raza, Belal Firwana, et al. · Journal of Clinical Oncology

Incidence of advanced prostate cancer in men under the age of 50 in the United States: A population-based study 1973-2010.

2014 · Uladzislau Naidzionak, Katsiaryna Ivanova, et al. · Journal of Clinical Oncology

A Restrospective Review Of Thrombophilia Evaluation At a Single Academic Institution

2013 · Uladzislau Naidzionak, Katsiaryna Ivanova, et al. · Blood

Works count: 7

Citation count: 47

H-index: 2

I10-index: 2